← back to search

Sven Hoffner

Karolinska Institutet · SE
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Infectious Diseases and Tuberculosis, and Diagnosis and treatment of tuberculosis.
h-index
40
citations
5,576
works
105
NIH funding
primary concept
email

Recent publications

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response
Clinical Infectious Diseases 2020cited by 52position: middledoi
Drivers and sites of diversity in the DNA adenine methylomes of 93 Mycobacterium tuberculosis complex clinical isolates
eLife 2020cited by 42position: middledoi
A standardised method for interpreting the association between mutations and phenotypic drug resistance in<i>Mycobacterium tuberculosis</i>
European Respiratory Journal 2017cited by 332position: middledoi
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
Nature Genetics 2017cited by 296position: middledoi
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
Nature Genetics 2016cited by 479position: middledoi
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
The Lancet Infectious Diseases 2016cited by 165position: middledoi
Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study
Journal of Antimicrobial Chemotherapy 2014cited by 91position: middledoi
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
Bulletin of the World Health Organization 2012cited by 103position: middledoi
Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing
Journal of Clinical Microbiology 2012cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pontus Juréen · Public Health Agency of Sweden2 papers (2012–2012) · 1 papers (2012–2012)Jan‐Willem C. Alffenaar · The University of Sydney1 papers (2020–2020)William R. Jacobs · Albert Einstein College of Medicine1 papers (2020–2020) · 1 papers (2012–2012)A. Engström · Gene Therapy Laboratory1 papers (2012–2012)Derek Conkle-Gutierrez · San Diego State University1 papers (2020–2020) · 1 papers (2012–2012) · 1 papers (2012–2012)Dick van Soolingen · Radboud Institute for Molecular Life Sciences1 papers (2014–2014)Judith Bruchfeld · Karolinska University Hospital1 papers (2020–2020)Enrico Tortoli · San Raffaele University of Rome1 papers (2014–2014)Xubin Zheng · Fudan University1 papers (2020–2020)Erik C. Böttger · University of Zurich1 papers (2014–2014)Christopher A. Morrissey · Pennsylvania State University1 papers (2020–2020)Sarah M. Ramirez-Busby · San Diego State University1 papers (2020–2020)Kristian Ängeby · Karolinska Institutet1 papers (2012–2012)Faramarz Valafar · University of San Diego1 papers (2020–2020)Scott N. Mitchell · San Diego State University1 papers (2020–2020) · 1 papers (2014–2014)